TY  - CONF

T1  - Efficacy and safety of dupilumab in children aged >= 6 months to < 6 years with moderate-to-severe atopic dermatitis

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2022/01/01

AU  - Paller AS

AU  - Simpson EL

AU  - Siegfried EC

AU  - Cork MJ

AU  - Wollenberg A

AU  - Arkwright PD

AU  - Soong W

AU  - Gonzalez ME

AU  - Schneider LC

AU  - Sidbury R

AU  - Lockshin B et al

ED  - 

VL  - 186

IS  - 4

SP  - E173

EP  - E173

Y2  - 2024/12/22

ER  -